The efficacy of irinotecan, paclitaxel, and oxaliplatin (IPO) in relapsed germ cell tumours with high-dose chemotherapy as consolidation: a non-cisplatin-based induction approach
Author:
Affiliation:
1. St Bartholomew's Hospital; London UK
2. Charing Cross Hospital; London UK
3. Guy's and St. Thomas’ NHS Foundation Trust; London UK
4. University College London Cancer Institute; London UK
5. Addenbrooke's Hospital; Cambridge UK
Funder
Orchid Cancer Appeal
Publisher
Wiley
Subject
Urology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/bju.13004/fullpdf
Reference17 articles.
1. Salvage therapy in recurrent germ cell cancer: ifosfamide and cisplatin plus either vinblastine or etoposide;Loehrer;Ann Intern Med,1988
2. Vinblastine plus ifosfamide plus cisplatin as initial salvage therapy in recurrent germ cell tumor;Loehrer;J Clin Oncol,1998
3. Combination of paclitaxel, ifosfamide, and cisplatin is an effective second-line therapy for patients with relapsed testicular germ cell tumors;Kondagunta;J Clin Oncol,2005
4. Sequential versus single high-dose chemotherapy in patients with relapsed or refractory germ cell tumors: long-term results of a prospective randomized trial;Lorch;J Clin Oncol,2012
5. Conventional-dose versus high-dose chemotherapy as first salvage treatment in male patients with metastatic germ cell tumors: evidence from a large international database;Lorch;J Clin Oncol,2011
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Balancing efficacy with long-term side-effects: can we safely de-escalate therapy for germ cell tumors?;Expert Review of Anticancer Therapy;2023-01-17
2. The Efficacy and Safety of Irinotecan, Paclitaxel and Oxaliplatin (IPO) Regimen as Salvage in Relapsed/Refractory Ovarian Germ Cell Tumors;Indian Journal of Gynecologic Oncology;2022-11-28
3. High‐dose chemotherapy for relapsed germ cell tumours: outcomes in low‐volume specialized centres;BJU International;2022-03-31
4. Adenocarcinoma Arising in a Yolk Sac Tumor of the Pineal Gland;Journal of Neuropathology & Experimental Neurology;2022-02-16
5. Autologous Stem Cell Transplantation in Testicular Germ Cell Tumor—Preliminary Experience from a Single Center;South Asian Journal of Cancer;2021-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3